Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypothalamic hormones and cancer.

A V Schally1, A M Comaru-Schally, A Nagy

  • 1Endocrine, Polypeptide, and Cancer Institute, Veterans Affairs Medical Center, 1601 Perdido Str., New Orleans, LA 70112, USA.

Frontiers in Neuroendocrinology
|October 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diffusion of contrast medium after perineural injection of the palmar nerves: an in vivo and in vitro study.

Equine veterinary journal·2009
Same author

Overlap of nigrothalamic terminals and thalamostriatal neurons in the feline lateralis medialis-suprageniculate nucleus.

Acta physiologica Hungarica·2009
Same author

Characterization of cross-section correction to charge exchange recombination spectroscopy rotation measurements using co- and counter-neutral-beam views.

The Review of scientific instruments·2008
Same author

Modeling the Pauli potential in the pair density functional theory.

The Journal of chemical physics·2008
Same author

Exact integral constraint requiring only the ground-state electron density as input on the exchange-correlation force - partial differential(V)(xc)(r)/partial differential(r) for spherical atoms.

The Journal of chemical physics·2008
Same author

Green Mold Diseases of Agaricus and Pleurotus spp. Are Caused by Related but Phylogenetically Different Trichoderma Species.

Phytopathology·2008

Peptide analogs offer new cancer therapies by targeting hormone pathways and directly affecting tumors. These novel treatments, including luteinizing hormone-releasing hormone (LH-RH) and somatostatin analogs, show promise for more effective cancer treatment.

Area of Science:

  • Oncology
  • Endocrinology
  • Peptide Therapeutics

Background:

  • Peptide analogs are increasingly utilized in cancer therapy.
  • Luteinizing hormone-releasing hormone (LH-RH) and somatostatin analogs are key examples.
  • Their mechanisms involve pituitary-gonadal axis inhibition and direct tumor effects.

Purpose of the Study:

  • To review the therapeutic applications of peptide analogs in various cancers.
  • To summarize research on tumoral hypothalamic hormones and their receptors.
  • To highlight emerging peptide-based therapeutic strategies.

Main Methods:

  • Review of existing literature on peptide analog therapy for cancer.
  • Analysis of studies on LH-RH, somatostatin, GH-RH, and bombesin/GRP roles in tumors.

Related Experiment Videos

  • Discussion of radiolabeled analogs for tumor localization.

    • Main Results:

    • LH-RH agonists/antagonists impact cancer via hormonal axis and direct tumor effects.
    • Somatostatin analogs are effective for tumor treatment and localization.
    • Tumoral GH-RH, bombesin/GRP, and their receptors are implicated in tumor proliferation.

    Conclusions:

    • New peptide analogs, including GH-RH and bombesin antagonists, are emerging as novel cancer treatments.
    • Cytotoxic peptide analogs can be targeted to specific cancer receptors.
    • These advancements hold potential for more effective cancer therapy and metastasis treatment.